Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Matteo is a biotechnology company focused on overcoming the challenges of oral delivery for large molecules, such as peptides and proteins. The company utilizes a proprietary formulation platform designed to protect therapeutic payloads from the harsh environment of the gastrointestinal tract while facilitating efficient absorption into the bloodstream. By transforming injectable biologics into oral formats, Matteo aims to improve patient compliance and expand access to life-changing therapies for chronic conditions like diabetes and obesity. The company was co-founded by prominent researchers from UCLA and MIT, leveraging deep expertise in bioengineering and molecular biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Matteo Formulation.